And there we go. Equal close on the low of the year…..so far.
All on paper profits gained after the E4 announcement have
now evaporated unfortunately. The market has spoken. Now if
that doesn’t speak louder than any market analysis by any
individuals or brokers for that matter, and people don’t take a
serious look at how they evaluate a company when the all
ordinaries are hovering around all time highs then there’s little
hope for change or genuine learning. The responsibility for the
Mayne share price destruction lies with management and the
strategies employed. I think that if a company is sitting on great
news it gets it out to the market to limit the share price damage.
Therefore it is a reasonable assumption to expect that confession
season isn’t likely to bring good news for long suffering retail share
holders unfortunately. If you are going to entrust your hard earned
by investing in a company it’s always a good place to start by looking
at management’s track record and sadly it hasn’t been great from my
perspective but others are entitled to disagree and look towards the
apparent blue skies ahead. Usually markets are forward looking and
if that’s the case with Myx then the future is looking pretty bleak. Perhaps
with Myx the market is backwards looking. Personally I’d rather sleep
well at night than risk my capital on management that most people agree
here has performed fairly inadequately over the last 5 years….
- Forums
- ASX - By Stock
- MYX
- General Discussion Topics
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.08

General Discussion Topics, page-227
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 810 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.15 | 2033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 5.080 |
1 | 1100 | 5.070 |
1 | 905 | 5.060 |
1 | 1000 | 5.050 |
3 | 4055 | 5.040 |
Price($) | Vol. | No. |
---|---|---|
5.150 | 2033 | 2 |
5.170 | 905 | 1 |
5.180 | 2396 | 2 |
5.190 | 5905 | 2 |
5.200 | 157 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online